(Photo from Pixabay) DOST Undersecretary Rowena Guevarra said there are currently more than 50 clinical trials worldwide for the use of Ivermectin as possible treatment against COVID-19. “Ang problema natin, walang solid na conclusion, merong nagsasabi na okay siya, merong nagsasabi na hindi siya okay (Our problem is, there is no solid conclusion. Some say it is okay, some say it is not),” Guevarra said in a public briefing Tuesday, May 25. In the Philippines, the Food and Drug Administration (FDA) has allowed the limited use of Ivermectin under the conditions of a compassionate special permit. “Sabi ng Philippine COVID-19 Living Clinical Practice Guidelines na nagsusuri ng current evidence sa Pilipinas at sa buong mundo, hindi pa rin sapat ang datos para mai-rekomenda ang paggamit ng Ivermectin bilang gamot sa mga pasyente na may mild to moderate COVID-19 (The Philippine COVID-19 Living Clinical Practice Guidelines, which examines current evidence in the Philippines and around the world, says there is still insufficient data to recommend the use of Ivermectin as a drug in patients with mild to moderate COVID-19,” she said.